17.03
price down icon2.57%   -0.45
pre-market  Pre-mercato:  17.02   -0.01   -0.06%
loading

Immunovant Inc Azioni (IMVT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Expenses
9.92%
127.22
115.74 94.28 80.88 61.55
Income/Loss From Continuing Operations Before Tax
9.78%
-119.70
-109.04 -87.07 -75.09 -51.53
Income Tax Expense/Benefit
1,071%
0.913
0.078 0.077 0.232 -0.108
Income/Loss From Continuing Operations After Tax
10.53%
-120.61
-109.12 -87.15 -75.32 -51.42
Net Income/Loss
10.53%
-120.61
-109.12 -87.15 -75.32 -51.42
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
16.66%
170.87
146.47 146.09 2.5233 144.52
Diluted Average Shares
16.66%
170.87
146.47 146.09 2.5233 144.52
Basic Earnings Per Share
4.05%
-0.71
-0.74 -0.60 -0.52 -0.36
Diluted Earnings Per Share
4.05%
-0.71
-0.74 -0.60 -0.52 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Capitalizzazione:     |  Volume (24 ore):